Abstract
Magnetosomes are specialized organelles arranged in intracellular chains in magnetotactic bacteria. The superparamagnetic property of these magnetite crystals provides potential applications as contrast-enhancing agents for magnetic resonance imaging. In this study, we compared two different nanoparticles that are bacterial magnetosome and HSA-coated iron oxide nanoparticles for targeting breast cancer. Both magnetosomes and HSA-coated iron oxide nanoparticles were chemically conjugated to fluorescent-labeled anti-EGFR antibodies. Antibody-conjugated nanoparticles were able to bind the MDA-MB-231 cell line, as assessed by flow cytometry. To compare the cytotoxic effect of nanoparticles, MTT assay was used, and according to the results, HSA-coated iron oxide nanoparticles were less cytotoxic to breast cancer cells than magnetosomes. Magnetosomes were bound with higher rate to breast cancer cells than HSA-coated iron oxide nanoparticles. While 250 μg/ml of magnetosomes was bound 92 ± 0.2%, 250 μg/ml of HSA-coated iron oxide nanoparticles was bound with a rate of 65 ± 5%. In vivo efficiencies of these nanoparticles on breast cancer generated in nude mice were assessed by MRI imaging. Anti-EGFR-modified nanoparticles provide higher resolution images than unmodified nanoparticles. Also, magnetosome with anti-EGFR produced darker image of the tumor tissue in T2-weighted MRI than HSA-coated iron oxide nanoparticles with anti-EGFR. In vivo MR imaging in a mouse breast cancer model shows effective intratumoral distribution of both nanoparticles in the tumor tissue. However, magnetosome demonstrated higher distribution than HSA-coated iron oxide nanoparticles according to fluorescence microscopy evaluation. According to the results of in vitro and in vivo study results, magnetosomes are promising for targeting and therapy applications of the breast cancer cells.
Similar content being viewed by others
Abbreviations
- BM:
-
Bacterial magnetosome
- HSA:
-
Human serum albumin
- SPIONs:
-
Superparamagnetic iron oxide nanoparticles
- HSA-SPIONs:
-
Human serum albumin-coated iron oxide nanoparticles
- MRI:
-
Magnetic resonance imaging
- Anti-EGFR:
-
Anti-epidermal growth factor receptor
References
Ondrusek, N., Warner, E., & Goel, V. (1999). Development of a knowledge scale about breast cancer and heredity (BCHK). Breast Cancer Research and Treatment, 53, 69–75.
What is Breast Cancer? 2004. Available from: http://www.cancer.ca.
Fernandez-Fernandez, A., Manchanda, R., & McGoron, A. J. (2011). Theranostic applications of nanomaterials in cancer: Drug delivery, image-guided therapy, and multifunctional platforms. Applied Biochemistry and Biotechnology, 165, 1628–1651.
Geva, T. (2006). Magnetic resonance imaging: Historical perspective. Journal of Cardiovascular Magnetic Resonance, 8, 573–580.
Stillman, M. J. (1977). Womens health beliefs about breast-cancer and breast self-examination. Nursing Research, 26, 121–127.
Boyd, N. F., Guo, H., Martin, L. J., Sun, L. M., Stone, J., Fishell, E., Jong, R. A., Hislop, G., Chiarelli, A., Minkin, S., & Yaffe, M. J. (2007). Mammographic density and the risk and detection of breast cancer. New England Journal of Medicine, 356, 227–236.
Smith, R. A., Cokkinides, V., von Eschenbach, A. C., Levin, B., Cohen, C., Runowicz, C. D., Sener, S., Saslow, D., & Eyre, H. J. (2002). American Cancer Society guidelines for the early detection of cancer. CA: A Cancer Journal for Clinicians, 52, 8–22.
Kuhl, C. (2007). The current status of breast MR imaging part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice 1. Radiology, 244, 356–378.
Kupfer, M. E., & Ogle, B. M. (2015). Advanced imaging approaches for regenerative medicine: Emerging technologies for monitoring stem cell fate in vitro and in vivo. Biotechnology Journal, 10, 1515–1528.
Adam, G., Dammer, M., Bohndorf, K., Christoph, R., Fenke, F., & Günther, R. (1991). Rheumatoid arthritis of the knee: Value of gadopentetate dimeglumine-enhanced MR imaging. AJR. American Journal of Roentgenology, 156, 125–129.
Port, M., Idee, J. M., Medina, C., Robic, C., Sabatou, M., & Corot, C. (2008). Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: A critical review. Biometals, 21, 469–490.
Felton, C., Karmakar, A., Gartia, Y., Ramidi, P., Biris, A. S., & Ghosh, A. (2014). Magnetic nanoparticles as contrast agents in biomedical imaging: Recent advances in iron- and manganese-based magnetic nanoparticles. Drug Metabolism Reviews, 46, 142–154.
Sun, C., Sze, R., & Zhang, M. (2006). Folic acid-PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI. Journal of Biomedical Materials Research Part A, 78, 550–557.
Chakraborty, M., Jain, S., & Rani, V. (2011). Nanotechnology: Emerging tool for diagnostics and therapeutics. Applied Biochemistry and Biotechnology, 165, 1178–1187.
LaVan, D. A., McGuire, T., & Langer, R. (2003). Small-scale systems for in vivo drug delivery. Nature Biotechnology, 21, 1184–1191.
Zhang, K., Yuan, K., Wu, H. Y., Li, Q., Wang, Y. L., Chen, S. H., Zhang, L. L., Gu, H., & Fu, R. Z. (2012). Identification of potential markers related to neoadjuvant chemotherapy sensitivity of breast cancer by SELDI-TOF MS. Applied Biochemistry and Biotechnology, 166, 753–763.
Majidi, S., Sehrig, F. Z., Farkhani, S. M., Goloujeh, M. S., & Akbarzadeh, A. (2016). Current methods for synthesis of magnetic nanoparticles. Artificial Cell Nanomedicine and Biotechnology, 44, 722–734.
Gubin, S. P., Koksharov, Y. A., Khomutov, G. B., & Yurkov, G. Y. (2005). Magnetic nanoparticles: Preparation methods, structure and properties. Usp Khim+, 74, 539–574.
Reetz, M. T., Helbig, W., & Quaiser, S. A. (1996). In A. Fürstner (Ed.), Active metals: Preparation, characterization, applications. Weinheim: Wiley-VCH Verlag GmbH.
Dai, Z. F., Meiser, F., & Mohwald, H. (2005). Nanoengineering of iron oxide and iron oxide/silica hollow spheres by sequential layering combined with a sol-gel process. Journal of Colloid and Interface Science, 288, 298–300.
Patra, S., Mukherjee, S., Barui, A. K., Ganguly, A., Sreedhar, B., & Patra, C. R. (2015). Green synthesis, characterization of gold and silver nanoparticles and their potential application for cancer therapeutics. Materials Science and Engineering C: Materials for Biological Applications, 53, 298–309.
Blakemore, R. (1975). Magnetotactic bacteria. Science, 190, 377–379.
Xie, J., Chen, K., & Chen, X. (2009). Production, modification and bio-applications of magnetic nanoparticles gestated by magnetotactic bacteria. Nano Research, 2, 261–278.
Bazylinski, D. A. (1996). Controlled biomineralization of magnetic minerals by magnetotactic bacteria. Chemical Geology, 132, 191–198.
Balkwill, D., Maratea, D., & Blakemore, R. (1980). Ultrastructure of a magnetotactic spirillum. Journal of Bacteriology, 141, 1399–1408.
Wahyudi, A. T., Takeyama, H., & Matsunaga, T. (2001). Isolation of Magnetospirillum magneticum AMB-1 mutants defective in bacterial magnetic particle synthesis by transposon mutagenesis. Applied Biochemistry and Biotechnology, 91-3, 147–154.
Lower, B. H., & Bazylinski, D. A. (2013). The bacterial Magnetosome: A unique prokaryotic organelle. Journal of Molecular Microbiology and Biotechnology, 23, 63–80.
Bazylinski, D. A., & Frankel, R. B. (2004). Magnetosome formation in prokaryotes. Nature Reviews. Microbiology, 2, 217–230.
Sun, J. B., Zhao, F., Tang, T., Jiang, W., Tian, J. S., Li, Y., & Li, J. L. (2008). High-yield growth and magnetosome formation by Magnetospirillum gryphiswaldense MSR-1 in an oxygen-controlled fermentor supplied solely with air. Applied Microbiology and Biotechnology, 79, 389–397.
Grunberg, K., Muller, E. C., Otto, A., Reszka, R., Linder, D., Kube, M., Reinhardt, R., & Schuler, D. (2004). Biochemical and proteomic analysis of the magnetosome membrane in Magnetospirillum gryphiswaldense. Applied and Environmental Microbiology, 70, 1040–1050.
Schuler, D. (2004). Molecular analysis of a subcellular compartment: The magnetosome membrane in Magnetospirillum gryphiswaldense. Archives of Microbiology, 181, 1–7.
Arakaki, A., Webb, J., & Matsunaga, T. (2003). A novel protein tightly bound to bacterial magnetic particles in Magnetospirillum magneticum strain AMB-1. The Journal of Biological Chemistry, 278, 8745–8750.
Sun, J., Li, Y., Liang, X.-J., & Wang, P. C. (2011). Bacterial magnetosome: A novel biogenetic magnetic targeted drug carrier with potential multifunctions. Journal of Nanomaterials, 2011, 9.
Nitin, N., LaConte, L. E. W., Zurkiya, O., Hu, X., & Bao, G. (2004). Functionalization and peptide-based delivery of magnetic nanoparticles as an intracellular MRI contrast agent. Journal of Biological Inorganic Chemistry, 9, 706–712.
Yu, J., Lee, C.-W., Im, S.-S., & Lee, J.-S. (2003). Structure and magnetic properties of SiO2 coated Fe2O3 nanoparticles synthesized by chemical vapor condensation process. Reviews on Advanced Materials Science, 4, 55–59.
Xia, D. L., Chen, Y. P., Chen, C., Wang, Y. F., Li, X. D., He, H., & Gu, H. Y. (2015). Comparative study of biosafety, DNA, and chromosome damage of different-materials-modified Fe3O4 in rats. Applied Biochemistry and Biotechnology, 177, 1069–1082.
Henoumont, C., Elst, L. V., Laurent, S., & Muller, R. N. (2009). Study of non-covalent interactions between MRI contrast agents and human serum albumin by NMR diffusometry. Journal of Biological Inorganic Chemistry, 14, 683–691.
Sugio, S., Kashima, A., Mochizuki, S., Noda, M., & Kobayashi, K. (1999). Crystal structure of human serum albumin at 2.5 Å resolution. Protein Engineering, 12, 439–446.
Ruuls, S. R., Lammerts van Bueren, J. J., van de Winkel, J. G., & Parren, P. W. (2008). Novel human antibody therapeutics: The age of the Umabs. Biotechnology Journal, 3, 1157–1171.
Zhang, Y., Zhang, X. J., Jiang, W., Li, Y., & Li, J. L. (2011). Semicontinuous culture of Magnetospirillum gryphiswaldense MSR-1 cells in an Autofermentor by nutrient-balanced and isosmotic feeding strategies. Applied and Environmental Microbiology, 77, 5851–5856.
Sun, J. B., Duan, J. H., Dai, S. L., Ren, J., Guo, L., Jiang, W., & Li, Y. (2008). Preparation and anti-tumor efficiency evaluation of doxorubicin-loaded bacterial magnetosomes: Magnetic nanoparticles as drug carriers isolated from Magnetospirillum gryphiswaldense. Biotechnology and Bioengineering, 101, 1313–1320.
Kavaz, D., Odabaş, S., Güven, E., Demirbilek, M., & Denkbaş, E. B. (2010). Bleomycin loaded magnetic chitosan nanoparticles as multifunctional nanocarriers. Journal of Bioactive and Compatible Polymers, 25, 305–318.
Lin, W., Coombes, A., Davies, M., Davis, S., & Illum, L. (1993). Preparation of sub-100 nm human serum albumin nanospheres using a pH-coacervation method. Journal of Drug Targeting, 1, 237–243.
Barral, J. K., Gudmundson, E., Stikov, N., Etezadi-Amoli, M., Stoica, P., & Nishimura, D. G. (2010). A robust methodology for in vivo T1 mapping. Magnetic Resonance in Medicine, 64, 1057–1067.
Zhang, Y., Kohler, N., & Zhang, M. Q. (2002). Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials, 23, 1553–1561.
Chi, K. R. (2009). Microscopy: Ever-increasing resolution. Nature, 462, 675–678.
Matsuda, Y., Schlange, T., Oakeley, E. J., Boulay, A., & Hynes, N. E. (2009). WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth. Breast Cancer Research, 11, R32.
Xu, J., Hu, J., Liu, L., Li, L., Wang, X., Zhang, H., Jiang, W., Tian, J., Li, Y., & Li, J. (2014). Surface expression of protein a on magnetosomes and capture of pathogenic bacteria by magnetosome/antibody complexes. Frontiers in Microbiology, 5, 136.
Xie, J., Wang, J., Niu, G., Huang, J., Chen, K., Li, X., & Chen, X. (2010). Human serum albumin coated iron oxide nanoparticles for efficient cell labeling. Chemical Communications, 46, 433–435.
Xiang, L., Wei, J., Jianbo, S., Guili, W., Feng, G., & Ying, L. (2007). Purified and sterilized magnetosomes from Magnetospirillum gryphiswaldense MSR-1 were not toxic to mouse fibroblasts in vitro. Letters in Applied Microbiology, 45, 75–81.
Wartlick, H., Michaelis, K., Balthasar, S., Strebhardt, K., Kreuter, J., & Langer, K. (2004). Highly specific HER2-mediated cellular uptake of antibody-modified nanoparticles in tumour cells. Journal of Drug Targeting, 12, 461–471.
Tkachenko, A. G., Xie, H., Liu, Y. L., Coleman, D., Ryan, J., Glomm, W. R., Shipton, M. K., Franzen, S., & Feldheim, D. L. (2004). Cellular trajectories of peptide-modified gold particle complexes: Comparison of nuclear localization signals and peptide transduction domains. Bioconjugate Chemistry, 15, 482–490.
Alphandery, E. (2014). Applications of magnetosomes synthesized by magnetotactic bacteria in medicine. Frontiers in Bioengineering and Biotechnology, 2, 5.
Sun, J. B., Tang, T., Duan, J. H., Xu, P. X., Wang, Z. L., Zhang, Y. D., Wu, L. Y., & Li, Y. (2010). Biocompatibility of bacterial magnetosomes: Acute toxicity, immunotoxicity and cytotoxicity. Nanotoxicology, 4, 271–283.
Alphandery, E., Faure, S., Seksek, O., Guyot, F., & Chebbi, I. (2011). Chains of Magnetosomes Extracted from AMB-1 Magnetotactic bacteria for application in alternative magnetic field cancer therapy. ACS Nano, 5, 6279–6296.
Ankamwar, B., Lai, T. C., Huang, J. H., Liu, R. S., Hsiao, M., Chen, C. H., & Hwu, Y. K. (2010). Biocompatibility of Fe3O4 nanoparticles evaluated by in vitro cytotoxicity assays using normal, glia and breast cancer cells. Nanotechnology, 21, 75102.
Han, L., Li, S., Yang, Y., Zhao, F., Huang, J., & Chang, J. (2007). Comparison of magnetite nanocrystal formed by biomineralization and chemosynthesis. Journal of Magnetism and Magnetic Materials, 313, 236–242.
Acknowledgements
This study was supported by Hacettepe University. Project number is 014BİYB604002.
The animal study protocol was approved by Animal Research Ethics Committee of Kobay A.Ş. Protocol number 106. 04.03.2014. There is no conflict of interest between authors.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
All methods used in this study were approved by Kobay Laboratory of Experimental Animals Ethics Committee (No:106, 2014).
Additional information
Highlights
Biosynthesis and extraction of magnetosome
Synthesis of superparamagnetic iron oxide nanoparticles
Design and development of nanoparticle for targeting to cancer cells
Generated of breast cancer in nude mice
Electronic Supplementary Material
ESM 1
(DOCX 192 kb)
Rights and permissions
About this article
Cite this article
Erdal, E., Demirbilek, M., Yeh, Y. et al. A Comparative Study of Receptor-Targeted Magnetosome and HSA-Coated Iron Oxide Nanoparticles as MRI Contrast-Enhancing Agent in Animal Cancer Model. Appl Biochem Biotechnol 185, 91–113 (2018). https://doi.org/10.1007/s12010-017-2642-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-017-2642-x